What to Know About GLP-1 Medications and Weight Management Programs
Learn how Eden connects patients to licensed providers to explore GLP-1 medications as part of medical weight management programs.
Explore how GLP-1 medications like semaglutide may help manage diabetes, support weight goals, & reduce cardiovascular risks with provider-guided care.
GLP-1 receptor agonists are a class of FDA-approved medications that play a vital role in the treatment of type 2 diabetes. These therapies not only improve blood sugar control but also support weight loss and may reduce cardiovascular risk in certain patients. Available as weekly injections or daily oral tablets, GLP-1 medications such as semaglutide are often prescribed when lifestyle changes and first-line therapies like metformin are insufficient.
This guide reviews how GLP-1 medications work, who may benefit from them, and what to expect when starting treatment. Eden connects patients with licensed healthcare providers who create personalized, evidence-based GLP-1 treatment plans using only FDA-approved medications. Compounded alternatives are not used.
GLP-1 receptor agonists mimic the body’s natural glucagon-like peptide-1 hormone, which is involved in glucose regulation and appetite control. GLP-1 medications help lower blood sugar through four main mechanisms:
These effects help stabilize blood glucose levels and improve overall metabolic health.
GLP-1 medications can lower hemoglobin A1C, a key marker of long-term glucose control, by up to 2 percentage points in clinical trials. Many patients reach or maintain their target A1C levels with GLP-1 therapy, especially when combined with dietary changes and physical activity.
For individuals who do not respond to metformin alone or who have additional health concerns, GLP-1 therapy may offer a more comprehensive approach to managing diabetes.
Some GLP-1 medications have demonstrated a reduction in major adverse cardiovascular events, including heart attack and stroke, particularly in patients with type 2 diabetes and existing cardiovascular disease.
Emerging data suggests GLP-1 therapy may slow kidney disease progression, likely due to improved glycemic control, weight loss, and reduced systemic inflammation.
GLP-1 therapy promotes modest but meaningful weight loss, which can further enhance insulin sensitivity, reduce blood pressure, and lower cholesterol. These are critical factors for individuals with type 2 diabetes.
GLP-1 medications may be prescribed for adults with type 2 diabetes who:
These medications are not typically recommended for individuals with a history of pancreatitis, certain thyroid tumors, or severe gastrointestinal disorders. They are also not approved for use during pregnancy or breastfeeding.
Eden’s network of licensed providers begins with a comprehensive medical evaluation, including your diabetes history, lab values, weight goals, and lifestyle habits.
GLP-1 injections are administered subcutaneously in the abdomen, thigh, or upper arm, with dosing once per week on the same day.
Most side effects are gastrointestinal and occur during dose escalation. These may include:
These typically resolve within a few weeks. Eating small, balanced meals and staying hydrated can help minimize symptoms.
GLP-1 therapy works best when combined with healthy habits:
Eden’s providers can help integrate lifestyle strategies into your treatment plan.
GLP-1 medications are a safe, effective, and well-studied option for people with type 2 diabetes seeking better blood sugar control, weight support, and long-term health protection. When managed by a licensed provider and combined with lifestyle improvements, GLP-1 therapy can help you make lasting progress.
Eden helps you get started with FDA-approved GLP-1 medications through clinician-guided programs. No compounded drugs and no guesswork. Just safe, evidence-based care tailored to your goals.
This content is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
You may see improved appetite and blood sugar stability within the first few weeks. A1C changes often take 8 to 12 weeks.
GLP-1s alone rarely cause hypoglycemia, but the risk may increase if used with insulin or sulfonylureas. Monitor levels as directed.
Moderation is key. Limit added sugars and refined carbohydrates to prevent blood sugar spikes.
Not always. Some patients may still need insulin. GLP-1s can reduce insulin needs but are not a substitute in every case.